Secondary Logo

Journal Logo

December 2005 - Volume 28 - Issue 6
pp: 537-643

Soft Tissue


A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases

Mackay, Helen J.; Billingsley, Kevin; Gallinger, Steven; More

American Journal of Clinical Oncology. 28(6):547-554, December 2005.

Efficacy and Tolerability of Oxaliplatin Plus Irinotecan 5-Fluouracil and Leucovorin Regimen in Advanced Stage Colorectal Cancer Patients Pretreated With Irinotecan 5-Fluouracil and Leucovorin

Stathopoulos, George P.; Rigatos, Sotiris K.; Stathopoulos, John G.; More

American Journal of Clinical Oncology. 28(6):565-569, December 2005.

Erlotinib and Chemoradiation Followed by Maintenance Erlotinib for Locally Advanced Pancreatic Cancer: A Phase I Study

Iannitti, David; Dipetrillo, Tom; Akerman, Paul; More

American Journal of Clinical Oncology. 28(6):570-575, December 2005.

Irinotecan (CPT-11) and Mitomycin-C (MMC) as Second-Line Therapy in Advanced Gastric Cancer: A Phase II Study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)

Giuliani, Francesco; Molica, Stefano; Maiello, Evaristo; More

American Journal of Clinical Oncology. 28(6):581-585, December 2005.


Normal Tissue Effects

Quality of Life

Developmental Therapeutics